| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | -69.7% |
| R&D Expense | $110.2M | +54.2% |
| SG&A Expense | $21.1M | +71.0% |
| Operating Income | -$129.1M | -68.6% |
| Pre-tax Income | -$145.2M | -77.6% |
| Income Tax | $3K | +50.0% |
| Net Income | -$145.2M | -77.6% |
| EPS (Basic) | -$3.62 | -68.4% |
| EPS (Diluted) | -$3.62 | -68.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $273.9M | +108.6% |
| Accounts Receivable | $243K | -34.9% |
| Current Assets | $280.5M | +101.6% |
| Total Assets | $290.9M | +93.3% |
| Current Liabilities | $27.6M | +22.8% |
| Total Liabilities | $232.8M | +137.4% |
| Stockholders' Equity | $58.1M | +10.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.3M | -43.5% |
| Capital Expenditures | $686K | -20.6% |
| Investing Cash Flow | -$686K | +15.2% |
| Financing Cash Flow | $258.6M | +208.6% |
| Free Cash Flow | -$116.0M | -42.9% |